Sunshine Biopharma Inc. (SBFM) Gross margin 2019–2025
Sunshine Biopharma Inc. (SBFM) gross margin by fiscal year — reported gross profit divided by reported revenue.
33.8%FY2025 · since FY2019: 47.7% → 33.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 33.8% | +3.2 pp |
| FY2024 | 30.6% | -4.0 pp |
| FY2023 | 34.6% | -4.4 pp |
| FY2022 | 39.0% | -9.4 pp |
| FY2021 | 48.4% | -15.4 pp |
| FY2020 | 63.8% | +16.1 pp |
| FY2019 | 47.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice